MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartlett, S. E.
Right arrow Articles by Whistler, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartlett, S. E.
Right arrow Articles by Whistler, J. L.
Molecular Interventions 2:134-136 (2002)
© 2002 American Society of Pharmacology and Experimental Therapeutics



Viewpoint

The Near-Death Experience of Delta Opioid Receptors Leads to New Drug Targets

Selena E. Bartlett1 and Jennifer L. Whistler1,2

1 Ernest Gallo Clinic and Research Center, Emeryville CA 94608, USA and
2 Department of Neurology, University of California, San Francisco, CA 94143, USA

SUMMARY

Petäjä-Repo et al. have published a recent article describing how ligands for delta opioid receptors can facilitate the maturation of delta opioid receptors at the endoplasmic reticulum (ER) and promote the surface expression of these receptors. Indeed, even antagonists of the receptor can promote receptor maturation. Bartlett and Whistler discuss the findings within the article and how chaperones can rescue immature receptors from proteasome-dependent degradation. Pharmacological interventions can be designed that target immature ER-bound receptors, and subsequently, facilitate their maturation or degradation to ameliorate pathological conditions associated with abnormal surface expression of receptors.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.